Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R. & D. Biocogency Laboratories
Nicosia, Cyprus
- Ownership
- Private
- Development stage
- Other
01
Overview
R. & D. Biocogency Laboratories is a privately held Cyprus-registered pharmaceutical and biotechnology group that, through its portfolio companies, manufactures and distributes generic drugs, colloidal systems, fine chemicals and nuclear medicine products, and conducts research on new drugs including for cancer; it operates mainly as an industrial and healthcare-services group and does not have clearly disclosed clinical-stage therapeutic programs.[1][5][7][8]
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on R. & D. Biocogency Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on R. & D. Biocogency Laboratories.